Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Oric Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 25.6K | Jun 12, 2024 | Direct | ||
RayzeBio, Inc. | Director | Employee Stock Option (right to buy) | 0 | Feb 26, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ORIC | Oric Pharmaceuticals, Inc. | Jun 12, 2024 | 1 | $0 | 4 | Jun 14, 2024 | Director |
RYZB | RayzeBio, Inc. | Feb 26, 2024 | 2 | $0 | 4 | Feb 27, 2024 | Director |
RYZB | RayzeBio, Inc. | Sep 14, 2023 | 0 | $0 | 3 | Sep 14, 2023 | Director |
ORIC | Oric Pharmaceuticals, Inc. | Jun 14, 2023 | 1 | $0 | 4 | Jun 15, 2023 | Director |
ORIC | Oric Pharmaceuticals, Inc. | Jun 17, 2022 | 1 | $0 | 4 | Jun 17, 2022 | Director |
ORIC | Oric Pharmaceuticals, Inc. | Nov 9, 2021 | 1 | $0 | 4 | Nov 10, 2021 | Director |
ORIC | Oric Pharmaceuticals, Inc. | Nov 9, 2021 | 0 | $0 | 3 | Nov 10, 2021 | Director |